HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal Systemic Inflammation Induces Inflammatory Reactions and Brain Apoptosis in a Pathogen-Specific Manner.

AbstractBACKGROUND:
After neonatal asphyxia, therapeutic hypothermia (HT) is the only proven treatment option. Although established as a neuroprotective therapy, benefit from HT has been questioned when infection is a comorbidity to hypoxic-ischaemic (HI) brain injury. Gram-negative and gram-positive species activate the immune system through different pathogen recognition receptors and subsequent immunological systems. In rodent models, gram-negative (lipopolysaccharide [LPS]) and gram-positive (PAM3CSK4 [PAM]) inflammation similarly increase neuronal vulnerability to HI. Interestingly, while LPS pre-sensitisation negates the neuroprotective effect of HT, HT is highly beneficial after PAM-sensitised HI brain injury.
OBJECTIVE:
We aimed to examine whether systemic gram-positive or gram-negative inflammatory sensitisation affects juvenile rat pups per se, without an HI insult.
METHODS:
Neonatal 7-day-old rats (n = 215) received intraperitoneal injections of vehicle (0.9% NaCl), LPS (0.1 mg/kg), or PAM (1 mg/kg). Core temperature and weight gain were monitored. Brain cytokine expression (IL-6, IL-1β, TNF-α, and IL-10, via PCR), apoptosis (cleaved caspase 3, via Western blots), and microglial activation (Iba1, via immunohistochemistry) were examined.
RESULTS:
LPS induced an immediate drop in core temperature followed by poor weight gain, none of which were seen after PAM. Furthermore, LPS induced brain apoptosis, while PAM did not. The magnitude and temporal profile of brain cytokine expression differed between LPS- and PAM-injected animals.
CONCLUSION:
These findings reveal sepsis-like conditions and neuroinflammation specific to the inflammatory stimulus (gram-positive vs. gram-negative) in the neonatal rat. They emphasise the importance of pre-clinical models being pathogen dependent, and should always be carefully tailored to their clinical scenario.
AuthorsMari Falck, Damjan Osredkar, Thomas Ragnar Wood, Elke Maes, Torun Flatebø, Hemmen Sabir, Marianne Thoresen
JournalNeonatology (Neonatology) Vol. 113 Issue 3 Pg. 212-220 ( 2018) ISSN: 1661-7819 [Electronic] Switzerland
PMID29275405 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 S. Karger AG, Basel.
Chemical References
  • Cytokines
  • Lipopeptides
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Pam(3)CSK(4) peptide
Topics
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Brain (drug effects, pathology)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Female
  • Gram-Negative Bacterial Infections
  • Gram-Positive Bacterial Infections
  • Hypothermia, Induced (methods)
  • Hypoxia-Ischemia, Brain (metabolism, pathology)
  • Inflammation (metabolism)
  • Lipopeptides (pharmacology)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Neurons (drug effects)
  • Neuroprotection
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: